Hedge Fund - Kynam Capital
Celldex Therapeutics Inc. (CLDX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $117,975,000 | 9.91% | 6,500,000 | $22.34 |
| 2 | 2024 - Q4 (2024-12-31) | $127,972,511 | 7.56% | 5,064,207 | $27.17 |
| 3 | 2024 - Q3 (2024-09-30) | $117,558,120 | 9.01% | 3,458,609 | $38.10 |
| 4 | 2024 - Q2 (2024-06-30) | $125,425,669 | 9.67% | 3,388,967 | $37.73 |
| 5 | 2024 - Q1 (2024-03-31) | $121,713,000 | 12.73% | 2,900,000 | $41.06 |
| 6 | 2023 - Q4 (2023-12-31) | $119,214,153 | 13.2% | 3,005,904 | $29.41 |
| 7 | 2023 - Q3 (2023-09-30) | $88,064,000 | 14.4% | 3,200,000 | $31.35 |
| 8 | 2023 - Q2 (2023-06-30) | $88,218,000 | 12.13% | 2,600,000 | $33.70 |
| 9 | 2023 - Q1 (2023-03-31) | $50,712,047 | 6.54% | 1,409,451 | $43.15 |
| 10 | 2022 - Q4 (2022-12-31) | $71,552,232 | 10.97% | 1,605,390 | $35.70 |
| 11 | 2022 - Q3 (2022-09-30) | $44,980,000 | 9.47% | 1,600,127 | $30.66 |
| 12 | 2022 - Q2 (2022-06-30) | $30,526,000 | 7.79% | 1,132,259 | $29.04 |
| 13 | 2022 - Q1 (2022-03-31) | $25,648,000 | 8.31% | 753,034 | $31.97 |
| 14 | 2021 - Q4 (2021-12-31) | $8,761,000 | 4.68% | 226,726 | $43.58 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:15.0000 on 2019-02-11